Fig. 6
From: Identification of a Notch transcriptomic signature for breast cancer
Analysis of the 20-gene signature score in the PROMIX breast cancer cohort. A The 20-gene signature score (ssGSEA) for three breast cancer subtypes (20 Luminal A, 27 Luminal B and 21 TNBC patients) at the onset (orange) and after two rounds of epirubicin and docetaxel treatment (blue). B Disease-free survival analysis (survival probability) of patients (n = 122 (28 TNBC; 42 LumA; 42 LumB)) according to Notch signature score (high (red) and low (blue) groups) at baseline. C Signature score in the primary tumours for TNBC patients with (Yes) or without (No) lymph node metastasis. (*p < 0.05)